Mon, June 25, 2012
[ Mon, Jun 25th 2012 ] - Market Wire
Myths or Factsa" Campaign
Sun, June 24, 2012
Sat, June 23, 2012
Fri, June 22, 2012
Thu, June 21, 2012
Wed, June 20, 2012
Tue, June 19, 2012
Mon, June 18, 2012
Sun, June 17, 2012
Sat, June 16, 2012
Fri, June 15, 2012
Thu, June 14, 2012
Wed, June 13, 2012
Tue, June 12, 2012
Mon, June 11, 2012
Sat, June 9, 2012
Fri, June 8, 2012
Thu, June 7, 2012

Calendar of Events - Report Highlights Arena Pharmaceuticals, Inc. and VIVUS, Inc.


//health-fitness.news-articles.net/content/2012/ .. hts-arena-pharmaceuticals-inc-and-vivus-inc.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


June 14, 2012 09:00 ET

Calendar of Events - Report Highlights Arena Pharmaceuticals, Inc. and VIVUS, Inc.

HONG KONG--(Marketwire - Jun 14, 2012) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Arena Pharmaceuticals, Inc. (NASDAQ: [ ARNA ]) and VIVUS, Inc. (NASDAQ: [ VVUS ]). Gain market insight with full analysis and research downloads available at [ www.BrightonMarkets.com/index.php?coa=ARNA&cob=VVUS ].

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Arena Pharmaceuticals, Inc. for its current position within the healthcare industry. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The full research report on Arena Pharmaceuticals, Inc. (NASDAQ: [ ARNA ]) is available here: [ www.BrightonMarkets.com/index.php?coa=ARNA ].

Brighton Markets has released research on VIVUS, Inc. for its changing role within the healthcare industry. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic drugs for underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes, and men's sexual health. The full research report on VIVUS, Inc. (NASDAQ: [ VVUS ]) is available here: [ www.BrightonMarkets.com/index.php?cob=VVUS ].

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.



Publication Contributing Sources